Insulin maker Sanofi-Aventis took a big hit last year with the Lantus-cancer scare. But that hasn’t stopped them from charging ahead in diabetes care. According to industry observers, the company’s new US Diabetes unit, fueled by a recent “acquisition binge,” is gearing up to “turn the diabetes world upside-down” with a full set of new offerings to help doctors help patients achieve better outcomes. Sounds intriguing!
I caught up last week with Dennis Urbaniak, Sanofi’s…
Read more »
Congratulations again to the innovative little Salem, NH-based company doing some killer work in glucose monitoring. Not only did AgaMatrix score the job when Sanofi-Aventis decided to go into glucose meter business recently, but now they’ve accomplished a breakthrough close to my own heart:
The WaveSense Jazz meter will be the first medical device ever to connect directly with the Apple iOS platform. A new download cable, which AgaMatrix was demonstrating at the ADA Conference…
Read more »
By
AmyT on
March 31, 2010
Today, Sanofi-Aventis announced that it’s getting into the glucose meter manufacturing business, by partnering with a small company known for highly accurate meter technology, AgaMatrix (makers of WaveSense products, based on a patented electrochemistry formula).
Reports say the new Sanofi-branded meters will be out later this year, and that this move is part of a larger strategy to help Sanofi offer a “full diabetes management solution” — beyond its insulins, Lantus and Apidra, and the…
Read more »
